BioCentury
ARTICLE | Company News

Lotus Tissue Repair, Shire deal

March 11, 2013 7:00 AM UTC

Shire disclosed in an SEC filing financial details of its acquisition of Lotus Tissue Repair. Shire acquired Lotus Tissue for $49.3 million up front, plus up to $275 million in milestones (see BioCent...